{"id":"placebo-valproate","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Dizziness"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Somnolence"},{"rate":"1-5%","effect":"Thrombocytopenia"},{"rate":"1-5%","effect":"Liver function abnormalities"},{"rate":"1-5%","effect":"Weight gain"},{"rate":"1-5%","effect":"Hair loss"},{"rate":"1-5%","effect":"Rash"},{"rate":"rare","effect":"Hepatotoxicity"}]},"_chembl":{"chemblId":"CHEMBL433","moleculeType":"Small molecule","molecularWeight":"166.20"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It does this by inhibiting the reuptake of gamma-aminobutyric acid (GABA), a neurotransmitter that helps to calm down brain activity, and by blocking the release of excitatory neurotransmitters such as glutamate and aspartate.","oneSentence":"Valproate is a mood stabilizer that works by reducing the activity of certain brain chemicals.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:28:59.808Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Seizure prevention"},{"name":"Bipolar disorder"}]},"trialDetails":[{"nctId":"NCT07140913","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine","status":"RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2025-10-08","conditions":"Mania, Bipolar Disorder","enrollment":424},{"nctId":"NCT06433635","phase":"PHASE4","title":"Sequential Multiple Assignment Randomized Trial for Bipolar Depression","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2024-10-01","conditions":"Bipolar I Disorder, Depression","enrollment":2726},{"nctId":"NCT05431595","phase":"PHASE2, PHASE3","title":"Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2022-07-19","conditions":"Delirium, Epileptics, Neuroleptics","enrollment":42},{"nctId":"NCT07226141","phase":"PHASE1, PHASE2","title":"Valproate for the Treatment of Residual Amblyopia","status":"NOT_YET_RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2026-01-01","conditions":"Amblyopia, Amblyopia Unilateral, Amblyopia, Anisometropic","enrollment":28},{"nctId":"NCT00306475","phase":"PHASE4","title":"Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)?","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2006-03","conditions":"Schizophrenia, Schizoaffective Disorder","enrollment":60},{"nctId":"NCT02446652","phase":"PHASE3","title":"Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer","status":"WITHDRAWN","sponsor":"National Institute of Cancerología","startDate":"2015-01-01","conditions":"Cervical Cancer","enrollment":""},{"nctId":"NCT00227266","phase":"PHASE2","title":"Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy","status":"COMPLETED","sponsor":"University of Utah","startDate":"2005-09","conditions":"Spinal Muscular Atrophy","enrollment":94},{"nctId":"NCT00211757","phase":"PHASE2","title":"Divalproex Sodium vs. Placebo in Childhood/Adolescent Autism","status":"COMPLETED","sponsor":"Montefiore Medical Center","startDate":"2002-09","conditions":"Autism","enrollment":27},{"nctId":"NCT03717909","phase":"PHASE2","title":"Efficacy and Safety Trial of Sodium Valproate, in Paediatric and Adult Patients With Wolfram Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Birmingham","startDate":"2018-12-28","conditions":"Wolfram Syndrome","enrollment":63},{"nctId":"NCT00145470","phase":"PHASE3","title":"12 Week Study of the Safety/Efficacy of Asenapine When Added to Lithium/Valproate in the Treatment of Bipolar Disorder (A7501008 / P05844 / MK-8274-017)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-06-02","conditions":"Bipolar Disorder","enrollment":326},{"nctId":"NCT06020898","phase":"PHASE2","title":"Sodium Valproate in Patients With Acute Ischemic Stroke","status":"UNKNOWN","sponsor":"RenJi Hospital","startDate":"2023-09-01","conditions":"Acute Ischemic Stroke","enrollment":40},{"nctId":"NCT00221429","phase":"PHASE3","title":"Lithium Versus Divalproex for Treating Pediatric Bipolar Disorder","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2001-03","conditions":"Bipolar Disorder","enrollment":153},{"nctId":"NCT02600507","phase":"PHASE3","title":"Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression","status":"COMPLETED","sponsor":"Intra-Cellular Therapies, Inc.","startDate":"2016-03-07","conditions":"Bipolar Depression","enrollment":529},{"nctId":"NCT00261443","phase":"PHASE4","title":"A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2005-09","conditions":"Bipolar Disorder","enrollment":1270},{"nctId":"NCT02899611","phase":"PHASE1, PHASE2","title":"A Dose Ranging Pilot Study for Intracerebroventricular (ICV) Delivery of Valproate in Subjects With Temporal Seizures","status":"COMPLETED","sponsor":"Cerebral Therapeutics LLC","startDate":"2016-08","conditions":"Epilepsy","enrollment":6},{"nctId":"NCT02607904","phase":"PHASE2","title":"An Open-label Extension Trial to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2016-12-15","conditions":"Epilepsy","enrollment":30},{"nctId":"NCT02607891","phase":"PHASE2","title":"A Study of Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2016-11-09","conditions":"Epilepsy","enrollment":35},{"nctId":"NCT03616223","phase":"PHASE1, PHASE2","title":"FX-322 in Sensorineural Hearing Loss","status":"COMPLETED","sponsor":"Frequency Therapeutics","startDate":"2018-07-03","conditions":"Sensorineural Hearing Loss","enrollment":23},{"nctId":"NCT03652974","phase":"PHASE4","title":"Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy","status":"COMPLETED","sponsor":"Shanghai Mental Health Center","startDate":"2018-09-06","conditions":"Schizophrenia","enrollment":145},{"nctId":"NCT01730313","phase":"PHASE2","title":"Treatment of Nodding Syndrome - A Randomized Blinded Placebo-Controlled Crossover Trial of Oral Pyridoxine and Conventional Anti-Epileptic Therapy, in Northern Uganda - 2012","status":"WITHDRAWN","sponsor":"Centers for Disease Control and Prevention","startDate":"2016-02","conditions":"Nodding Syndrome","enrollment":""},{"nctId":"NCT00484471","phase":"PHASE4","title":"ABLE: Abilify in Bipolar Disorder for Long-term Effectiveness","status":"COMPLETED","sponsor":"Korea Otsuka International Asia Arab","startDate":"2007-10","conditions":"Bipolar Disorder","enrollment":127},{"nctId":"NCT00145509","phase":"PHASE3","title":"40 Week Trial to Study the Safety of Asenapine When Added to Lithium or Valproate in the Treatment of Bipolar Disorder (A7501009)(P05786)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-08","conditions":"Bipolar Disorder","enrollment":77},{"nctId":"NCT04531592","phase":"PHASE2","title":"Valproic Acid (VPA) for Acute Kidney Injury (AKI) in Liver Transplant Patients","status":"WITHDRAWN","sponsor":"Westat","startDate":"2022-01","conditions":"Acute Kidney Injury, Ischemia Reperfusion Injury","enrollment":""},{"nctId":"NCT04531579","phase":"PHASE2","title":"Valproic Acid (VPA) for Acute Kidney Injury (AKI) in Trauma Patients","status":"WITHDRAWN","sponsor":"Westat","startDate":"2022-01","conditions":"Acute Kidney Injury, Ischemia Reperfusion Injury","enrollment":""},{"nctId":"NCT00078754","phase":"PHASE2","title":"A Comparison of Fluoxetine and Divalproex for the Treatment of Intermittent Explosive Disorder","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2003-05","conditions":"Intermittent Explosive Disorder","enrollment":90},{"nctId":"NCT00312494","phase":"PHASE3","title":"3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2006-04","conditions":"Bipolar Disorder","enrollment":680},{"nctId":"NCT00483548","phase":"PHASE3","title":"Adjunctive Ziprasidone in the Treatment of Bipolar I Depression","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2007-10","conditions":"Bipolar Disorder, Depression, Bipolar","enrollment":298},{"nctId":"NCT04035798","phase":"PHASE2, PHASE3","title":"add-on Low Dose Memantine in Middle-to-old Aged Bipolar II Disorder Patients","status":"UNKNOWN","sponsor":"National Cheng-Kung University Hospital","startDate":"2019-08-01","conditions":"Bipolar II Disorder","enrollment":120},{"nctId":"NCT04671589","phase":"PHASE4","title":"Antidote for Valproic Acid Toxicity: a New Indication for Meropenem Antibiotic.","status":"UNKNOWN","sponsor":"Mabaret Al-Asafara Hospitals","startDate":"2021-06","conditions":"Drug Toxicity","enrollment":48},{"nctId":"NCT00221403","phase":"PHASE3","title":"Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2004-09","conditions":"Bipolar Disorder","enrollment":46},{"nctId":"NCT03590197","phase":"PHASE4","title":"Effect of Melatonin on Seizure Outcome, Neuronal Damage and Quality of Life in Patients With Generalized Epilepsy","status":"COMPLETED","sponsor":"All India Institute of Medical Sciences, Bhubaneswar","startDate":"2018-08-06","conditions":"Generalized Epilepsy","enrollment":104},{"nctId":"NCT03204500","phase":"PHASE2","title":"Dual Treatment With Lithium and Valproate in ALS.","status":"COMPLETED","sponsor":"El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez","startDate":"2016-05","conditions":"Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis, Sporadic","enrollment":43},{"nctId":"NCT00579280","phase":"PHASE4","title":"Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD","status":"COMPLETED","sponsor":"University of South Florida","startDate":"2007-07","conditions":"Bipolar Disorder, Panic Disorder, Generalized Anxiety Disorder","enrollment":224},{"nctId":"NCT01900730","phase":"PHASE2","title":"Study of Valproic Acid (VPA) vs Placebo to Shorten Time of Indwelling Pleural Catheter","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2014-07-31","conditions":"Breast Cancer","enrollment":3},{"nctId":"NCT00167934","phase":"NA","title":"Determining Metabolic Effects of Valproate and Antipsychotic Therapy","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2004-12","conditions":"Schizophrenia","enrollment":164},{"nctId":"NCT01760785","phase":"NA","title":"Valproate for Mood Swings and Alcohol Use Following Head Injury","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2008-09","conditions":"Traumatic Brain Injury (TBI), Alcoholism","enrollment":50},{"nctId":"NCT01674010","phase":"PHASE2","title":"Safety and Efficacy Study of ELND005 as an Adjunctive Maintenance Treatment in Bipolar I Disorder","status":"TERMINATED","sponsor":"OPKO Health, Inc.","startDate":"2012-08","conditions":"Bipolar 1 Disorder","enrollment":309},{"nctId":"NCT01729598","phase":"EARLY_PHASE1","title":"Valproic Acid in Subjects With Intact Cognition - Proof of Concept Study","status":"COMPLETED","sponsor":"Gregory Jicha, 323-5550","startDate":"2012-04","conditions":"Alzheimer's Disease","enrollment":14},{"nctId":"NCT00194116","phase":"PHASE3","title":"Double-blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar II Depression","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2004-09","conditions":"Bipolar Disorder","enrollment":54},{"nctId":"NCT02343575","phase":"PHASE4","title":"Valproic Acid for Treatment of Hyperactive or Mixed Delirium in ICU","status":"TERMINATED","sponsor":"Stanford University","startDate":"2015-01","conditions":"Hyperactive Delirium, Mixed Delirium","enrollment":3},{"nctId":"NCT00643123","phase":"PHASE4","title":"Allopurinol Add-on Treatment for Refractory Mania","status":"COMPLETED","sponsor":"Cedars-Sinai Medical Center","startDate":"2007-09","conditions":"Bipolar Disorder, Mixed Mania, Treatment-Resistant Mania","enrollment":40},{"nctId":"NCT01928849","phase":"PHASE2","title":"Valproic Acid for the Prevention of Post-Amputation Pain","status":"COMPLETED","sponsor":"Duke University","startDate":"2013-12","conditions":"Pain, Phantom, Pain, Neuropathic","enrollment":128},{"nctId":"NCT02456454","phase":"PHASE3","title":"Controlled Trial of Valproate Versus Risperidone in Young Children With Bipolar Disorder","status":"COMPLETED","sponsor":"Nationwide Children's Hospital","startDate":"2006-01","conditions":"Bipolar Disorder","enrollment":46},{"nctId":"NCT01791868","phase":"NA","title":"Efficacy Study of Intravenous Sodium Valproate in Addition to First Line Anti Epileptic Treatment of Generalized Convulsive Status Epilepticus.","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2013-02","conditions":"Generalized Convulsive Status Epilepticus, Intensive Care Unit","enrollment":245},{"nctId":"NCT02789813","phase":"PHASE2","title":"Influence of Valproic Acid on Extinction-based Therapy in Patients With Fear of Spiders.","status":"COMPLETED","sponsor":"Prof. Dominique de Quervain, MD","startDate":"2016-07","conditions":"Phobia, Specific","enrollment":100},{"nctId":"NCT00183443","phase":"PHASE3","title":"Treatment of Mania Symptoms With Drug Therapy","status":"COMPLETED","sponsor":"Palo Alto Veterans Institute for Research","startDate":"2005-02","conditions":"Bipolar Disorder, Schizophrenia","enrollment":75},{"nctId":"NCT00194129","phase":"PHASE3","title":"Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar Disorder and Substance Abuse Disorder","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"1997-11","conditions":"Bipolar Disorder","enrollment":31},{"nctId":"NCT02011750","phase":"PHASE4","title":"Pilot Trial of Valproate as Adjunctive Treatment for Toxoplasma Gondii Infection in Early Course Schizophrenia","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2013-04-01","conditions":"Toxoplasmosis, Schizophrenia","enrollment":109},{"nctId":"NCT02625779","phase":"PHASE2","title":"Combined Cytidine and Creatine-containing Drug in the Treatment of the Bipolar Depression","status":"WITHDRAWN","sponsor":"Ewha Womans University Mokdong Hospital","startDate":"2016-03-01","conditions":"Depression, Bipolar","enrollment":""},{"nctId":"NCT01543139","phase":"PHASE2","title":"Cytidine- and Creatine-Containing Drug in Treating Bipolar Depression","status":"WITHDRAWN","sponsor":"Ewha Womans University","startDate":"2015-12-01","conditions":"Bipolar Depression","enrollment":""},{"nctId":"NCT02608736","phase":"EARLY_PHASE1","title":"Chemoprevention of Head and Neck Squamous Cell Carcinoma (HNSCC) With Valproic Acid","status":"COMPLETED","sponsor":"Barretos Cancer Hospital","startDate":"2015-12","conditions":"Head and Neck Squamous Cell Carcinoma","enrollment":42},{"nctId":"NCT00000439","phase":"PHASE2","title":"Drug Treatment for Alcoholics With Bipolar Disorder","status":"COMPLETED","sponsor":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","startDate":"2000-10","conditions":"Alcoholism, Bipolar Disorder","enrollment":72},{"nctId":"NCT01233609","phase":"PHASE2","title":"Trial of Oral Valproic Acid for Retinitis Pigmentosa","status":"COMPLETED","sponsor":"Foundation Fighting Blindness","startDate":"2010-11","conditions":"Retinitis Pigmentosa","enrollment":90},{"nctId":"NCT02872428","phase":"PHASE1","title":"A Study to Evaluate the Safety and Tolerability of Valproic Acid in Trauma Patients(Part 2)","status":"TERMINATED","sponsor":"Dr. Hasan Alam","startDate":"2016-11","conditions":"Shock,Hemorrhagic, Trauma","enrollment":1},{"nctId":"NCT00218114","phase":"PHASE3","title":"Divalproex Sodium (Depakote) for Explosive Tempers in Adolescents and Adults","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2000-02","conditions":"Attention Deficit and Disruptive Behavior Disorders, Marijuana Abuse","enrollment":25},{"nctId":"NCT02593643","phase":"EARLY_PHASE1","title":"Effect of Ketamine vs. Active Placebo on Suicidal Ideation in Depressed Inpatients With Major Depressive Disorder or Bipolar Depression.","status":"COMPLETED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2016-01","conditions":"Major Depressive Disorder, Bipolar I Disorder, Bipolar II Disorder","enrollment":9},{"nctId":"NCT03039842","phase":"PHASE3","title":"Combination of Dextromethorphan and Memantine in Treating Bipolar Disorder","status":"UNKNOWN","sponsor":"National Cheng-Kung University Hospital","startDate":"2013-01-01","conditions":"Bipolar Disorder II","enrollment":300},{"nctId":"NCT01170325","phase":"PHASE2","title":"A Study of Divalproex Sodium in Children With ASD and Epileptiform EEG","status":"WITHDRAWN","sponsor":"National Institute of Mental Health (NIMH)","startDate":"2010-06-30","conditions":"Autism, Autism Spectrum Disorders","enrollment":""},{"nctId":"NCT00609245","phase":"PHASE4","title":"Effect of Valproic Acid Concentration on Photic Response","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2007-12","conditions":"Photosensitive Epilepsy","enrollment":13},{"nctId":"NCT00183469","phase":"PHASE4","title":"Maintenance Treatment of Bipolar Depression","status":"COMPLETED","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2004-12","conditions":"Bipolar Disorder, Depression","enrollment":86},{"nctId":"NCT01784666","phase":"PHASE2","title":"Adjunctive Isradipine for the Treatment of Bipolar Depression","status":"TERMINATED","sponsor":"Massachusetts General Hospital","startDate":"2013-02","conditions":"Bipolar Disorder","enrollment":2},{"nctId":"NCT00226343","phase":"PHASE4","title":"Depakote-ER for Depressive and Bipolar Depression","status":"COMPLETED","sponsor":"Cambridge Health Alliance","startDate":"2003-08","conditions":"Bipolar Disorder","enrollment":25},{"nctId":"NCT00562861","phase":"PHASE2, PHASE3","title":"Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram","status":"COMPLETED","sponsor":"Tufts Medical Center","startDate":"2007-11","conditions":"Bipolar Disorder, Bipolar Depression","enrollment":119},{"nctId":"NCT00217932","phase":"PHASE2","title":"Effectiveness of Divalproex Sodium (Depakote) in Treating Children With Temper Outbursts and Severe Mood Swings","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2000-09","conditions":"Mood Disorders","enrollment":15},{"nctId":"NCT02078596","phase":"PHASE4","title":"Depakote (Divalproex Sodium) for Children With Temper Dysregulation and Severe Mood Swings","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"1997-03","conditions":"Irritable Aggression","enrollment":15},{"nctId":"NCT01951560","phase":"PHASE1","title":"A Study to Evaluate the Safety and Tolerability of Valproic Acid in Healthy Volunteers (Part 1)","status":"COMPLETED","sponsor":"Dr. Hasan Alam","startDate":"2013-09","conditions":"Shock,Hemorrhagic","enrollment":59},{"nctId":"NCT00481013","phase":"PHASE2","title":"Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy","status":"COMPLETED","sponsor":"University of Utah","startDate":"2007-07","conditions":"Spinal Muscular Atrophy","enrollment":33},{"nctId":"NCT00063362","phase":"PHASE3","title":"Combination Therapy for the Treatment of Bipolar Disorders","status":"TERMINATED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2002-02","conditions":"Bipolar Disorder","enrollment":49},{"nctId":"NCT02094651","phase":"PHASE2","title":"Treatment of Children With Autism Spectrum Disorders and Epileptiform EEG With Divalproex Sodium","status":"WITHDRAWN","sponsor":"Boston Children's Hospital","startDate":"2014-04","conditions":"Autism","enrollment":""},{"nctId":"NCT00240110","phase":"PHASE1, PHASE2","title":"Valproate Efficacy in Cocaine-Bipolar Comorbidity","status":"COMPLETED","sponsor":"University of Miami","startDate":"2006-03","conditions":"Bipolar Disorder, Cocaine Dependence","enrollment":152},{"nctId":"NCT01358357","phase":"PHASE3","title":"Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex","status":"COMPLETED","sponsor":"Sumitomo Pharma America, Inc.","startDate":"2011-06","conditions":"Bipolar I Disorder","enrollment":965},{"nctId":"NCT00302133","phase":"PHASE1, PHASE2","title":"Optimizing Pharmacotherapy for Bipolar Alcoholics","status":"COMPLETED","sponsor":"University of Miami","startDate":"2006-05","conditions":"Bipolar Disorder, Alcohol Dependence","enrollment":88},{"nctId":"NCT01467700","phase":"PHASE3","title":"Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder","status":"TERMINATED","sponsor":"Takeda","startDate":"2011-12","conditions":"Acute Depressive Episode","enrollment":490},{"nctId":"NCT00287053","phase":"PHASE4","title":"Effects of Divalproex Sodium on Food Intake, Energy Expenditure, and Posture Allocation","status":"COMPLETED","sponsor":"Pennington Biomedical Research Center","startDate":"2006-02","conditions":"Healthy","enrollment":57},{"nctId":"NCT01671384","phase":"PHASE3","title":"Valproate and Levocarnitine in Children With Spinal Muscular Atrophy","status":"UNKNOWN","sponsor":"All India Institute of Medical Sciences","startDate":"2013-08","conditions":"Spinal Muscular Atrophy","enrollment":60},{"nctId":"NCT01977300","phase":"PHASE3","title":"Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2003-01","conditions":"Bipolar I Disorder","enrollment":159},{"nctId":"NCT00108576","phase":"PHASE3","title":"Divalproex Sodium in the Treatment of PTSD (Post-Traumatic Stress Disorder)","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2003-10","conditions":"PTSD","enrollment":101},{"nctId":"NCT01619644","phase":"PHASE2","title":"Rubinstein-Taybi Syndrome: Functional Imaging and Therapeutic Trial","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2012-04","conditions":"Rubinstein-Taybi Syndrome","enrollment":41},{"nctId":"NCT00141505","phase":"PHASE2","title":"PK Effects of Bifeprunox & Valproate in Bipolar I","status":"COMPLETED","sponsor":"Solvay Pharmaceuticals","startDate":"2005-02","conditions":"Bipolar I Disorder","enrollment":""},{"nctId":"NCT00221975","phase":"PHASE3","title":"Combination Therapy in Dual Diagnosis Bipolar Rapid Cycling","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2002-07","conditions":"Bipolar Disorder","enrollment":98},{"nctId":"NCT00071721","phase":"PHASE3","title":"Valproate in Dementia (VALID)","status":"COMPLETED","sponsor":"Alzheimer's Disease Cooperative Study (ADCS)","startDate":"2003-10","conditions":"Alzheimer Disease","enrollment":313},{"nctId":"NCT01115959","phase":"PHASE4","title":"Seizures Post Intracerebral Hemorrhage","status":"COMPLETED","sponsor":"Wolfson Medical Center","startDate":"2003-02","conditions":"Post Cerebral Hemorrhage","enrollment":72},{"nctId":"NCT00868452","phase":"PHASE3","title":"Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)","status":"COMPLETED","sponsor":"Sumitomo Pharma America, Inc.","startDate":"2009-04","conditions":"Bipolar Depression","enrollment":348},{"nctId":"NCT02027987","phase":"PHASE1","title":"Traumatic Neuroprotection and Epilepsy Prevention of Valproate Acid","status":"UNKNOWN","sponsor":"Xijing Hospital","startDate":"2013-10","conditions":"Traumatic Brain Injury","enrollment":160},{"nctId":"NCT00665366","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of Aripiprazole Administered With Lithium or Valproate Over 12 Weeks in the Treatment of Mania in Bipolar I Disorder","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2008-06","conditions":"Bipolar Disorder Mania","enrollment":493},{"nctId":"NCT01284517","phase":"PHASE3","title":"Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression","status":"COMPLETED","sponsor":"Sumitomo Pharma America, Inc.","startDate":"2010-11","conditions":"Bipolar Depression","enrollment":356},{"nctId":"NCT00228046","phase":"PHASE4","title":"Medication Strategies for Treating Aggressive Behavior in Youth With Attention Deficit Hyperactivity Disorder","status":"COMPLETED","sponsor":"Stony Brook University","startDate":"2004-01","conditions":"Attention Deficit Disorder With Hyperactivity, Conduct Disorder, Oppositional Defiant Disorder","enrollment":40},{"nctId":"NCT01188265","phase":"PHASE3","title":"Add-on Dextromethorphan in Bipolar Disorders","status":"COMPLETED","sponsor":"National Cheng-Kung University Hospital","startDate":"2007-06","conditions":"Bipolar Disorder","enrollment":300},{"nctId":"NCT01188148","phase":"PHASE2, PHASE3","title":"Series Studies of Bipolar Disorder-Valproate add-on Memantine","status":"COMPLETED","sponsor":"National Cheng-Kung University Hospital","startDate":"2009-08","conditions":"Bipolar Disorders","enrollment":219},{"nctId":"NCT00114686","phase":"PHASE3","title":"Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar Disorder","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2006-01","conditions":"Bipolar I Disorder, Alcohol Dependence","enrollment":350},{"nctId":"NCT00385710","phase":"PHASE2","title":"Trial of Valproic Acid in Patients With Progressive Supranuclear Palsy (Depakine)","status":"COMPLETED","sponsor":"Nantes University Hospital","startDate":"2006-11","conditions":"Progressive Supranuclear Palsy","enrollment":28},{"nctId":"NCT01548066","phase":"PHASE2","title":"The Efficacy and Safety of Topical Valproic Acid in Preventing Hair Loss","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2011-09","conditions":"Androgenetic Alopecia, Male Pattern Baldness","enrollment":40},{"nctId":"NCT00794625","phase":"PHASE4","title":"Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study)","status":"UNKNOWN","sponsor":"Joseph Blader","startDate":"2008-11","conditions":"Attention Deficit Disorder With Hyperactivity","enrollment":270},{"nctId":"NCT01460563","phase":"NA","title":"Valproic Acid, Magnesium Sulphate, Rocuronium Requirement, Postoperative Analgesia","status":"UNKNOWN","sponsor":"Seoul National University Bundang Hospital","startDate":"2011-10","conditions":"Cerebral Aneurysm","enrollment":60},{"nctId":"NCT00309686","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2006-04","conditions":"Affective Psychosis, Bipolar, Bipolar Disorder, Mania","enrollment":300},{"nctId":"NCT00545675","phase":"PHASE4","title":"Abilify in Bipolar Disorder for 24 Weeks Treatment Effectiveness","status":"COMPLETED","sponsor":"Korea Otsuka Pharmaceutical Co., Ltd.","startDate":"2007-12","conditions":"Bipolar Disorder","enrollment":146},{"nctId":"NCT00278772","phase":"PHASE3","title":"Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomania or Mild Mania","status":"COMPLETED","sponsor":"Lindner Center of HOPE","startDate":"2003-08","conditions":"Bipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild Mania","enrollment":62},{"nctId":"NCT00202514","phase":"PHASE2, PHASE3","title":"Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms","status":"COMPLETED","sponsor":"Seattle Institute for Biomedical and Clinical Research","startDate":"2004-09","conditions":"Alcoholism, Alcohol Related Disorders, Mood Disorders","enrollment":40},{"nctId":"NCT00402324","phase":"PHASE4","title":"A Comparison of Olanzapine in Combination With a Mood Stabilizer vs Mood Stabilizer Alone, in Mixed Bipolar Patients","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2006-12","conditions":"Bipolar I Disorder","enrollment":202},{"nctId":"NCT00532818","phase":"PHASE3","title":"Hydralazine Valproate for Cervical Cancer","status":"UNKNOWN","sponsor":"National Institute of Cancerología","startDate":"2007-07","conditions":"Metastatic Cervical Cancer","enrollment":143}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"placebo+valproate","genericName":"placebo+valproate","companyName":"National Cheng-Kung University Hospital","companyId":"national-cheng-kung-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Valproate is a mood stabilizer that works by reducing the activity of certain brain chemicals. Used for Seizure prevention, Bipolar disorder.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}